Biofrontera BFRI
NASDAQ BFRI
$1.46 +0.04 (+2.82%)
As of: Aug 20, 2026 · 3:52 PM EDT

Biofrontera (BFRI) Operating Margin Growth (5y) (2025 - 2026)

Biofrontera (BFRI) Operating Margin Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.85 Bn 42.88 Bn -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn -
10 Biofrontera 18.87 Mn 14.16 Mn 9.59 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5,861.00
Dec 31, 2025 2,885.00
Sep 30, 2025 -1,776.00